U.S. RESEARCH ROUNDUP- Cara Therapeutics, DT Midstream, Fulcrum Therapeutics
08/03/2022 07:09
March 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Cara Therapeutics, DT Midstream and Fulcrum
Therapeutics, on Tuesday.
HIGHLIGHTS
* Cara Therapeutics Inc CARA.O : JP Morgan raises to overweight from neutral
* DT Midstream Inc DTM.N : Credit Suisse cuts to neutral from outperform
* Fulcrum Therapeutics Inc FULC.O : Oppenheimer initiates with outperform rating
* Passage Bio Inc PASG.O : JP Morgan cuts to neutral from overweight
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.
* 908 Devices Inc. MASS.O : SVB Leerink cuts target price to $30 from $40
* Agilon Health Inc AGL.N : JP Morgan cuts target price to $37 from $42
* Agios Pharmaceuticals Inc AGIO.O : JP Morgan cuts target price to $50 from $57
* Alpine Immune Sciences Inc ALPN.O : Oppenheimer cuts target price to $17 from $19
* Annexon Inc ANNX.O : JP Morgan cuts target price to $24 from $37
* Asana Inc ASAN.N : Jefferies cuts target price to $50 from $65
* Avidxchange Holdings Inc AVDX.O : Credit Suisse cuts target price to $16 from $24
* Avidxchange Holdings Inc AVDX.O : JP Morgan cuts target price to $13 from $29
* Avidxchange Holdings Inc AVDX.O : Piper Sandler cuts target price to $13 from $25
* Bed Bath & Beyond Inc BBBY.O : Telsey Advisory Group raises target price to $18 from $15
* Cara Therapeutics Inc CARA.O : JP Morgan raises to overweight from neutral
* Cara Therapeutics Inc CARA.O : JP Morgan raises target price to $20 from $17
* Cheniere Energy Inc LNG.A : RBC raises target price to $151 from $116
* Cheniere Energy Partners LP CQP.A : RBC raises target price to $52 from $46
* Comerica Inc CMA.N : Piper Sandler cuts target price to $95 from $105
* CTO Realty Growth Inc CTO.N : BTIG raises target price to $72 from $67
* DT Midstream Inc DTM.N : Credit Suisse cuts to neutral from outperform
* DT Midstream Inc DTM.N : Credit Suisse raises target price to $58 from $55
* Elevation Oncology Inc ELEV.O : JP Morgan cuts target price to $13 from $21
* Equitrans Midstream Corp ETRN.N : Credit Suisse cuts target price to $9 from $13
* First Solar Inc FSLR.O : Credit Suisse cuts target price to $82 from $88
* Fulcrum Therapeutics Inc FULC.O : Oppenheimer initiates with outperform rating
* Fulcrum Therapeutics Inc FULC.O : Oppenheimer initiates with target price $33
* Goodrx Holdings Inc GDRX.O : Jefferies cuts target price to $22 from $47
* Informatica Inc INFA.N : JP Morgan cuts target price to $32 from $37
* Intercept Pharmaceuticals Inc ICPT.O : Canaccord Genuity cuts PT to $29 from $31
* Intra-Cellular Therapies Inc ITCI.O : JP Morgan raises target price to $55 from $49
* Kodiak Sciences Inc KOD.O : JP Morgan cuts target price to $20 from $21
* Kohls Corp KSS.N : Credit Suisse cuts target price to $60 from $70
* Limelight Networks Inc LLNW.O : D.A. Davidson raises target price to $4 from $3.75
* Oasis Petroleum Inc OAS.O : Truist Securities raises target price to $207 from $180
* Passage Bio Inc PASG.O : JP Morgan cuts to neutral from overweight
* Scholar Rock Holding Corp SRRK.O : Jefferies cuts target price to $18 from $28
* Sprinklr Inc CXM.N : Citigroup cuts price target to $14 from $17
* Squarespace Inc SQSP.N : JP Morgan cuts target price to $47 from $70
* Squarespace Inc SQSP.N : RBC cuts target price to $22 from $39
* Switch Inc SWCH.N : Jefferies raises target price to $33 from $31
* Thredup Inc TDUP.O : Piper Sandler cuts target price to $19 from $34
* Two Harbors Investment Corp TWO.N : Credit Suisse cuts target price to $5.25 from $6
* UDR Inc UDR.N : JP Morgan raises target price to $63 from $62
* Upwork Inc UPWK.O : Jefferies cuts target price to $21 from $32
* Upwork Inc UPWK.O : Piper Sandler cuts target price to $30 from $40
* Y-Mabs Therapeutics Inc YMAB.O : JP Morgan cuts target price to $17 from $27
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))